ROBO1 and lung carcinoma: Further, our combined prognosis showed that the combined high expression of SP5, FOXP1, ROBO1, DPP4, CDYL2, and STAMBPL1 is associated to patients’ better clinical prognosis of patients with lung cancer (Fig. 3f).